BI 1356 BS - single rising dose
Sponsors
Boehringer Ingelheim
Conditions
Diabetes Mellitus, Type 2Healthy
Phase 1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS in Patients With Type 2 Diabetes
CompletedNCT02183350
Start: 2005-04-30Updated: 2014-07-08
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses and Multiple Rising Oral Doses of BI 1356 BS in Healthy Male Volunteers
CompletedNCT02183311
Start: 2006-06-30Updated: 2014-07-08